Junfeng Wu, Ph.D. - Publications

Affiliations: 
2010 Boston University, Boston, MA, United States 
Area:
Biochemistry

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Bergholz J, Zhang Y, Wu J, Meng L, Walsh EM, Rai A, Sherman MY, Jim Xiao ZX. ΔNp63α regulates Erk signaling via MKP3 to inhibit cancer metastasis Oncogene. 33: 212-224. PMID 23246965 DOI: 10.1038/Onc.2012.564  0.322
2013 Du W, Yi Y, Zhang H, Bergholz J, Wu J, Ying H, Zhang Y, Xiao ZX. Rapamycin inhibits IGF-1-mediated up-regulation of MDM2 and sensitizes cancer cells to chemotherapy. Plos One. 8: e63179. PMID 23638184 DOI: 10.1371/Journal.Pone.0063179  0.329
2010 Wu J, Bergholz J, Lu J, Sonenshein GE, Xiao ZX. TAp63 is a transcriptional target of NF-kappaB. Journal of Cellular Biochemistry. 109: 702-10. PMID 20052674 DOI: 10.1002/Jcb.22449  0.447
2009 Du W, Wu J, Walsh EM, Zhang Y, Chen CY, Xiao ZX. Nutlin-3 affects expression and function of retinoblastoma protein: role of retinoblastoma protein in cellular response to nutlin-3. The Journal of Biological Chemistry. 284: 26315-21. PMID 19648117 DOI: 10.1074/Jbc.M109.046904  0.325
2008 Qiu W, Wu J, Walsh EM, Zhang Y, Chen CY, Fujita J, Xiao ZXJ. Retinoblastoma protein modulates gankyrin-MDM2 in regulation of p53 stability and chemosensitivity in cancer cells Oncogene. 27: 4034-4043. PMID 18332869 DOI: 10.1038/Onc.2008.43  0.315
Show low-probability matches.